For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Theriva Biologics Inc (AMEX: TOVX) closed at $0.28 in the last session, up 1.43% from day before closing price of $0.27. In other words, the price has increased by $1.43 from its previous closing price. On the day, 1.47 million shares were traded. TOVX stock price reached its highest trading level at $0.2783 during the session, while it also had its lowest trading level at $0.2622.
Ratios:
We take a closer look at TOVX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.19 and its Current Ratio is at 1.19. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.21.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOVX now has a Market Capitalization of 9352630 and an Enterprise Value of -6568447.
Stock Price History:
The Beta on a monthly basis for TOVX is 0.35, which has changed by -0.8494624 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, TOVX has reached a high of $2.22, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is -29.76%, while the 200-Day Moving Average is calculated to be -63.29%.
Shares Statistics:
According to the various share statistics, TOVX traded on average about 14.33M shares per day over the past 3-months and 6933930 shares per day over the past 10 days. A total of 33.74M shares are outstanding, with a floating share count of 33.64M. Insiders hold about 1.04% of the company’s shares, while institutions hold 0.91% stake in the company. Shares short for TOVX as of 1760486400 were 387988 with a Short Ratio of 0.03, compared to 1757894400 on 331552. Therefore, it implies a Short% of Shares Outstanding of 387988 and a Short% of Float of 4.05.
Earnings Estimates
Theriva Biologics Inc (TOVX) is presently subject to a detailed evaluation by 1.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.37 and low estimates of -$0.37.
Analysts are recommending an EPS of between -$2.15 and -$2.15 for the fiscal current year, implying an average EPS of -$2.15. EPS for the following year is -$0.75, with 1.0 analysts recommending between -$0.75 and -$0.75.
